1.
J Investig Allergol Clin Immunol
; 31(4): 362-363, 2021 Jul 26.
Article
in English
| MEDLINE
| ID: mdl-33856347
Subject(s)
Asthma/prevention & control , Asthma/physiopathology , Biological Therapy , COVID-19/epidemiology , Adolescent , Adult , Aged , Asthma/epidemiology , Asthma/therapy , COVID-19/physiopathology , COVID-19/therapy , Female , Hospitalization , Humans , Lung/physiopathology , Male , Middle Aged , Prevalence , Retrospective Studies , SARS-CoV-2
2.
J. investig. allergol. clin. immunol
; 31(4): 362-363, 2021. tab
Article
in English
| IBECS
| ID: ibc-215238
Subject(s)
Humans , Male , Female , Adolescent , Young Adult , Adult , Middle Aged , Aged , Aged, 80 and over , Asthma/therapy , Biological Therapy , Coronavirus Infections/complications , Pneumonia, Viral/complications , Pandemics , Severity of Illness Index , Retrospective Studies , Asthma/physiopathology , Prevalence
3.
Rev. patol. respir
; 23(3): 111-113, jul.-sept. 2020.
Article
in Spanish
| IBECS
| ID: ibc-198474
ABSTRACT
La amebiasis es una enfermedad infecciosa causada por el protozoo E. hystolitica con múltiples manifestaciones clínicas. La afectación torácica es la segunda localización extraintestinal más frecuente tras la hepática. Presentamos un caso de derrame pleural secundario a un absceso hepático amebiano y realizamos una revisión de esta entidad poco frecuente
Amebiasis is an infectious disease caused by the protozoan E. hystolitica with multiple clinical manifestations. Chest involvement is the second most frequent extraintestinal location after the liver. We present a case of pleural effusion secondary to an amebic liver abscess and we review this rare entity